JOURNAL OF THE CHINESE
CHEMICAL SOCIETY
Nano-WO3-supported Sulfonic Acid: A Reusable Catalyst
1
alyst, the obtained solution was titrated by standard solution of
0.1 N NaOH in the presence of a pH meter.
1304, 1121, 1096, 850, 800; H NMR (CDCl3, 300 MHz): d
(ppm): 2.20 (s, 6 H), 3.56 (s, 6 H), 4.91 (s, 1 H), 6.39 (s, 1 H),
7.16-6.76 (m, 4 H); 13C NMR (CDCl3, 75 MHz): d (ppm): 19.28,
38.71, 51.03, 103.49, 114.83, 129.01, 129.12, 143.49, 144.78,
168.21.
General procedure for the synthesis of 2,6-Dimethyl-
4-phenyl-1,4-dihydropyridine-3,5-diethylcarboxylate: A mix-
ture of ethyl acetoacetate (2 mmol, 0.26 g), benzaldehyde (1
mmol, 0.106 g), ammonium acetate (1.5 mmol, 0.115 g) and
n-WSA (0.021 g) was stirred at 100 °C under solvent-free condi-
tion for an appropriate time. Completion of the reaction was mon-
itored by TLC (n-hexane: ethyl acetate, 7:3). Then, the reaction
mixture was cooled, diluted with hot ethanol and stirred for few
minutes. The catalyst was removed by centrifugation and the re-
sultant alcoholic solution was poured into the ice water. The solid
product was filtered and then recrystallized from ethanol to give
pure yellow crystalline 2,6-Dimethyl-4-phenyl-1,4-dihydropyri-
dine-3,5-diethylcarboxylate in 98%. The catalyst can be reused
directly for the next run.
2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,
5-dimethylcarboxylate (Table 5, entry 19): IR (KBr, cm-1):
1
3349, 3005, 2953, 1704, 1650, 1528; H NMR (CDCl3, 300
MHz): d (ppm): 2.26 (s, 6 H), 3.56 (s, 6 H), 5.02 (s, 1 H), 6.29 (s, 1
H), 8.01-7.26 (m, 4 H); 13C NMR (CDCl3, 75 MHz): d (ppm):
19.44, 39.60, 51.16, 102.88, 121.39, 122.69, 128.76, 134.24,
146.37, 148.31, 149.65, 167.67.
ACKNOWLEDGEMENTS
We thank the Department of Chemistry of Semnan
University for supporting this work.
Spectral data of some compounds
2,6-Dimethyl-4-phenyl-1,4-dihydropyridine-3,5-diethyl
carboxylate (Table 5, entry 1): IR (KBr, cm-1): 3342, 1691,
REFERENCES
1. Bülbül, B.; Öztürk, G. S.; Vural, M.; ÔimÕek, R.; Sariolu, Y.;
Linden, A.; Ülgen, M.; Ôafak, C. Eur. J. Med. Chem. 2009,
44, 2052.
1
1643, 1489, 1210, 779; H NMR (CDCl3, 300 MHz): d (ppm):
1.15 (t, 6 H, J = 6.91 Hz), 2.22 (s, 6 H), 4.0 (b, 4 H), 4.93 (s, 1 H),
6.2 (b, 1 H), 7.04-7.22 (m, 5 H); 13C NMR (CDCl3, 75 MHz): d
(ppm): 14.26, 19.40, 39.63, 59.74, 103.93, 126.10, 127.84,
127.98, 144.23, 147.85, 167.81.
2. Yamamoto, T.; Niwa, S.; Ohno, S.; Tokumasu, M.;
Masuzawa, Y.; Nakanishi, C.; Nakajo, A.; Onishi, T.;
Koganei, H.; Fujita, S.-I. Bioorg. Med. Chem. Lett. 2008, 18,
4813.
2,6-Dimethyl-4-(4-chlorophenyl)-1,4-dihydropyridine-
3,5-diethylcarboxylate (Table 5, entry 3): IR (KBr, cm-1): 3335,
3. Yamamoto, T.; Ohno, S.; Niwa, S.; Tokumasu, M.; Hagihara,
M.; Koganei, H.; Fujita, S.-I.; Takeda, T.; Saitou, Y.;
Iwayama, S.; Takahara, A.; Iwata, S.; Shoji, M. Bioorg. Med.
Chem. Lett. 2011, 21, 3317.
1
1695, 1645, 1499, 1219, 789; H NMR (CDCl3, 300 MHz): d
(ppm): 1.3 (t, 6 H, J = 7.13 Hz), 2.19 (s, 6 H), 4 (b, 4 H), 4.89 (s, 1
H), 6.30 (s, 1 H), 7.15-7.06 (q, 4 H); 13C NMR (CDCl3, 75 MHz):
d (ppm): 14.27, 19.31, 39.24, 59.85, 103.50, 127.92, 129.36,
131.66, 144.56, 146.45, 167.68.
4. Natale, N. R.; Rogers, M. E.; Staples, R.; Triggle, D. J.;
Rutledge, A. J. Med. Chem. 1999, 42, 3087.
5. Kappe, C. O.; Fabian, W. M.; Semones, M. A. Tetrahedron
1997, 53, 2803.
2,6-Dimethyl-4-(4-hydroxyphenyl)-1,4-dihydropyridine-
3,5-diethylcarboxylate (Table 5, entry 9): IR (KBr, cm-1): 3443,
3341, 1698, 1640, 1493, 1213, 778; 1H NMR (CDCl3, 300 MHz):
d (ppm): 1.11 (t, 6 H, J = 7.11 Hz), 2.23 (s, 6 H), 3.05 (b, 4 H), 4.86
(s, 1 H), 7.04-6.56 (m, 4 H), 7.98 (s, 1H); 13C NMR (Acetone D,
75 MHz): d (ppm): 13.77, 17.87, 38.54, 58.87, 103.39, 114.40,
128.83, 139.76, 144.38, 155.54, 167.23.
6. Abbas, H.-AS.; El Sayed, W. A.; Fathy, N. M. Eur. J. Med.
Chem. 2010, 45, 973.
7. Kumar, R. S.; Idhayadhulla, A.; Nasser, A. J. A.; Kavimani,
S.; Indumathy, S. Indian J. Pharm. Sci. 2010, 72, 719.
8. Hilgeroth, A. Mini Rev. Med. Chem. 2002, 2, 235.
9. Refat, H. M.; Fadda, A. Eur. J. Med. Chem. 2013, 70, 419.
10. Rueping, M.; Dufour, J.; Schoepke, F. R. Green Chem. 2011,
13, 1084.
2,6-Dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dimet-
hylcarboxylate (Table 5, entry 13): IR (KBr, cm-1): 3317, 1692,
11. Chen, J.; McNeil, A. J. J. Am. Chem. Soc. 2008, 130, 16496.
12. Tafer, R.; Boulcina, R.; Carboni, B.; Debache, A. J. Chin.
Chem. Soc. 2012, 59, 1555.
1
1648, 1477, 1205, 765; H NMR (CDCl3, 300 MHz): d (ppm):
13. Debache, A.; Ghalem, W.; Boulcina, R.; Belfaitah, A.;
Rhouati, S.; Carboni, B. Tetrahedron Lett 2009, 50, 5248.
14. Sharma, S. D.; Hazarika, P.; Konwar, D. Catal. Commun.
2008, 9, 709.
2.23 (s, 6 H), 3.75 (s, 6 H), 4.95 (s, 1 H), 6.09 (b, 1 H), 7.14-7.21
(m, 4 H); 13C NMR (CDCl3, 75 MHz): d (ppm): 19.41, 39.28,
51.03, 103.64, 126.23, 127.60, 128.05, 144.61, 147.48, 168.22.
2,6-Dimethyl-4-(4-flourophenyl)-1,4-dihydropyridine-
3,5-dimethylcarboxylate (Table 5, entry 16): IR (KBr, cm-1)
3351, 3248, 3102, 3002, 2950, 2843, 1698, 1654, 1503, 1443,
15. Kahandal, S. S.; Kale, S. R.; Gawande, M. B.; Jayaram, R. V.
Catal. Sci. Technol. 2014, 4, 672.
16. Shafiee, M.; Reza, M.; Ghashang, M.; Fazlinia, A. Curr.
J. Chin. Chem. Soc. 2016, 63, 336-344
© 2016 The Chemical Society Located in Taipei & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
343